navitoclax,ruxolitinib
abbvie
['mpnsm', '#mpn', '#myelof', 'navitoclax', 'refine ']
congress | #eha2022 | giuseppe palumbo, university of catania, reported preliminary data from jaki-exposed pts with #myelofibrosis receiving navitoclax monotherapy (cohort 2) in the refine trial #mpnsm
- manageable safety profile
- lower rates of thrombocytopenia vs navitoclax + 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm